Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Next-generation IOLs advance complex cataract care
OCT changes with low-level red light therapy for myopia in children
Alcon presenting at APACRS 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Editor Choice
Managing challenging pterygium removal: Amniotic membrane grafting strategies | Ophthalmology Times
(Image Credit: AdobeStock/Sangiao_Photography) Pterygium is a common ocular surface disorder characterized by…
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease | Ophthalmology Times
(Image Credit: AdobeStock/SnapVault) Argenx SE has discontinued the phase 3 UplighTED studies…
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy | Ophthalmology Times
(Image Credit: AdobeStock/9dreamstudio) Aviceda Therapeutics has released topline results from its phase…
Advantages of Neurogenic Stimulation and Identifying Ideal Dry Eye Candidates for Acoltremon | Ophthalmology Times
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
The Role of TRPM8 Agonists in Dry Eye Disease | Ophthalmology Times
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA | Ophthalmology Times
(Image Credit: AdobeStock) Inflammasome Therapeutics has completed enrollment in a multicenter phase…
FDA approves Amneal Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05%. | Ophthalmology Times
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine…
The Art and Science of Presbyopia Correction: Navigating the IOL Patient Journey | Ophthalmology Times
Presbyopia-correcting IOLs have undergone a dramatic transformation in recent years. The once-limited…
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada | Ophthalmology Times
(Image Credit: AdobeStock/platinumArt) Health Canada has approved Celltrion’s Eydenzelt, a biosimilar referencing…
Worth Reading
Meeting expectations with evolving technology
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Osheru Receives Funding for Ziplyft Device for Blepharoplasty
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Subscribe Now
Enter your email address below and subscribe to our newsletter






















